Lexaria Bioscience (LEXX)
NASDAQ:LEXX
US Market
Holding LEXX?
Track your performance easily

Lexaria Bioscience (LEXX) Stock Investors

178 Followers
Based on 766,063 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold LEXX
On average, investors allocate 0.00% of their portfolios to LEXX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 766,063 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding LEXX

1.7%
Last 7
Days
3.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding LEXX, out of 766,063 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

LEXX Investor Activity

Action
Any
Any
Investor Performance
Any
Any
No data currently available
Based on the activity of 14,654 investors who made their portfolios public
The table shows changes in LEXX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

LEXX Investors Also Bought

Investor Type
Any
Any
All Investors
Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Sirius XM Holdings
3.50%
-0.55%
+1.70%
8.86B
Communication Services
Viking Therapeutics
4.93%
+0.69%
+5.26%
7.63B
Healthcare
Riot Platforms
5.31%
+0.17%
+1.75%
4.26B
Financial
Plug Power
5.22%
>-0.01%
+0.14%
1.81B
Industrials
Abbott Laboratories
3.57%
+0.46%
+13.29%
202.22B
Healthcare
CVS Health
3.95%
-0.68%
-0.29%
69.89B
Healthcare
Marathon Digital Holdings
5.76%
+0.26%
+0.42%
5.67B
Financial
RTX
4.17%
+2.60%
+6.39%
164.45B
Industrials
Carnival
6.49%
+1.32%
+8.73%
30.17B
Consumer Cyclical
Enphase Energy
4.60%
-0.58%
+3.62%
9.04B
Technology
Based on the activity of 766,063 active portfolios
Open your Smart Portfolio

LEXX Investor Analysis

LEXX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
9.1%
of LEXX holders
are under 35
Average Segment Performance
Average P/E Ratio26.57
Beta9.43
Dividend Yield51.54%
LEXX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
36.4%
of LEXX holders
are between 35–55
Average Segment Performance
Average P/E Ratio24.84
Beta18.28
Dividend Yield25.17%
LEXX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
54.5%
of LEXX holders
are over 55
Average Segment Performance
Average P/E Ratio23.97
Beta8.44
Dividend Yield41.02%
Overview of age group and performance of LEXX stock investors
See who invests in LEXX according to age group and performance.

FAQ

How many retail Investors hold LEXX?
<0.1% of TipRanks' retail investors hold LEXX in their portfolios.
    What is LEXX Investor Sentiment?
    LEXX’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of LEXX in the last 7 days?
      ▼ 1.7% of TipRanks' retail investors changed their holding of LEXX in the last 7 days.
        What percentage of retail investors changed their holding of LEXX in the last 30 days?
        ▼ 3.0% of TipRanks' retail investors changed their holding of LEXX in the last 30 days.
          What is the average age of retail investors who hold LEXX?
          The average age of LEXX Holders is over 55.
            What other stocks have LEXX investors also bought?
            LEXX Investors also bought SIRI, VKTX, RIOT, PLUG, ABT, CVS, MARA, RTX, CCL, ENPH.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ABTAbbott Laboratories
              AAgilent
              BDXBecton Dickinson
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis